These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8223992)
1. A case of lipoatrophy with human insulin-therapy. Chantelau E; Reuter M; Schotes S; Starke AA Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992 [TBL] [Abstract][Full Text] [Related]
5. A case of lipoatrophy with insulin detemir. Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121 [TBL] [Abstract][Full Text] [Related]
6. Lipoatrophy with insulin analogues in type I diabetes. Babiker A; Datta V Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843 [TBL] [Abstract][Full Text] [Related]
7. Severe lipoatrophy with human insulin: successfully treated by CSII. Chantelau E; Reuter M; Schotes S; Starke AA Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099 [No Abstract] [Full Text] [Related]
9. Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus. Peteiro-González D; Fernández-Rodríguez B; Cabezas-Agrícola JM; Araújo-Vilar D Diabetes Res Clin Pract; 2011 Mar; 91(3):e61-3. PubMed ID: 21146887 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of insulin lipoatrophy. A case report. Asherov J; Mimouni M; Laron Z Diabete Metab; 1979 Mar; 5(1):1-3. PubMed ID: 571820 [TBL] [Abstract][Full Text] [Related]
12. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus. Szypowska A; Skórka A; Pańkowska E Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of the effects of chromatographically purified insulin TZF-Polfa and highly purified insulin Nordisk on insulin-induced lipoatrophy]. Leowski J; Tatoń J; Czech A; Laz R Pol Tyg Lek; 1987 Dec; 42(50):1577-80. PubMed ID: 3330794 [No Abstract] [Full Text] [Related]
14. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin. Imakado S; Hamada K; Atsumi Y Diabetes Res Clin Pract; 2009 Sep; 85(3):e42-3. PubMed ID: 19520450 [TBL] [Abstract][Full Text] [Related]
15. Lipoatrophy is a thing of the past, or is it? Hussein SF; Siddique H; Coates P; Green J Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201 [TBL] [Abstract][Full Text] [Related]
16. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Holstein A; Stege H; Kovacs P Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763 [TBL] [Abstract][Full Text] [Related]
18. A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication. Ampudia-Blasco FJ; Girbes J; Carmena R Diabetes Care; 2005 Dec; 28(12):2983. PubMed ID: 16306570 [No Abstract] [Full Text] [Related]
19. Lispro insulin-induced lipoatrophy: a new case. Al-Khenaizan S; Al Thubaiti M; Al Alwan I Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067 [TBL] [Abstract][Full Text] [Related]
20. Injection site lipoatrophy: a rare complication of recombinant human insulin. Chakraborty PP; Bhattacharjee R J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114 [No Abstract] [Full Text] [Related] [Next] [New Search]